Cargando…

Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps

BACKGROUND: Chronic rhinosinusitis with nasal polyps is associated with local immunoglobulin hyperproduction and the presence of IgE antibodies against Staphylococcus aureus enterotoxins (SAEs). Aspirin-exacerbated respiratory disease is a severe form of chronic rhinosinusitis with nasal polyps in w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiun-Bo, James, Louisa K., Davies, Anna M., Wu, Yu-Chang Bryan, Rimmer, Joanne, Lund, Valerie J., Chen, Jou-Han, McDonnell, James M., Chan, Yih-Chih, Hutchins, George H., Chang, Tse Wen, Sutton, Brian J., Kariyawasam, Harsha H., Gould, Hannah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380656/
https://www.ncbi.nlm.nih.gov/pubmed/27658758
http://dx.doi.org/10.1016/j.jaci.2016.06.066
_version_ 1782519787940741120
author Chen, Jiun-Bo
James, Louisa K.
Davies, Anna M.
Wu, Yu-Chang Bryan
Rimmer, Joanne
Lund, Valerie J.
Chen, Jou-Han
McDonnell, James M.
Chan, Yih-Chih
Hutchins, George H.
Chang, Tse Wen
Sutton, Brian J.
Kariyawasam, Harsha H.
Gould, Hannah J.
author_facet Chen, Jiun-Bo
James, Louisa K.
Davies, Anna M.
Wu, Yu-Chang Bryan
Rimmer, Joanne
Lund, Valerie J.
Chen, Jou-Han
McDonnell, James M.
Chan, Yih-Chih
Hutchins, George H.
Chang, Tse Wen
Sutton, Brian J.
Kariyawasam, Harsha H.
Gould, Hannah J.
author_sort Chen, Jiun-Bo
collection PubMed
description BACKGROUND: Chronic rhinosinusitis with nasal polyps is associated with local immunoglobulin hyperproduction and the presence of IgE antibodies against Staphylococcus aureus enterotoxins (SAEs). Aspirin-exacerbated respiratory disease is a severe form of chronic rhinosinusitis with nasal polyps in which nearly all patients express anti-SAEs. OBJECTIVES: We aimed to understand antibodies reactive to SAEs and determine whether they recognize SAEs through their complementarity-determining regions (CDRs) or framework regions. METHODS: Labeled staphylococcal enterotoxin (SE) A, SED, and SEE were used to isolate single SAE-specific B cells from the nasal polyps of 3 patients with aspirin-exacerbated respiratory disease by using fluorescence-activated cell sorting. Recombinant antibodies with “matched” heavy and light chains were cloned as IgG(1), and those of high affinity for specific SAEs, assayed by means of ELISA and surface plasmon resonance, were recloned as IgE and antigen-binding fragments. IgE activities were tested in basophil degranulation assays. RESULTS: Thirty-seven SAE-specific, IgG- or IgA-expressing B cells were isolated and yielded 6 anti-SAE clones, 2 each for SEA, SED, and SEE. Competition binding assays revealed that the anti-SEE antibodies recognize nonoverlapping epitopes in SEE. Unexpectedly, each anti-SEE mediated SEE-induced basophil degranulation, and IgG(1) or antigen-binding fragments of each anti-SEE enhanced degranulation by the other anti-SEE. CONCLUSIONS: SEEs can activate basophils by simultaneously binding as antigens in the conventional manner to CDRs and as superantigens to framework regions of anti-SEE IgE in anti-SEE IgE-FcεRI complexes. Anti-SEE IgG(1)s can enhance the activity of anti-SEE IgEs as conventional antibodies through CDRs or simultaneously as conventional antibodies and as “superantibodies” through CDRs and framework regions to SEEs in SEE–anti-SEE IgE-FcεRI complexes.
format Online
Article
Text
id pubmed-5380656
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Mosby
record_format MEDLINE/PubMed
spelling pubmed-53806562017-04-12 Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps Chen, Jiun-Bo James, Louisa K. Davies, Anna M. Wu, Yu-Chang Bryan Rimmer, Joanne Lund, Valerie J. Chen, Jou-Han McDonnell, James M. Chan, Yih-Chih Hutchins, George H. Chang, Tse Wen Sutton, Brian J. Kariyawasam, Harsha H. Gould, Hannah J. J Allergy Clin Immunol Rhinitis, Sinusitis, and Upper Airway Disease BACKGROUND: Chronic rhinosinusitis with nasal polyps is associated with local immunoglobulin hyperproduction and the presence of IgE antibodies against Staphylococcus aureus enterotoxins (SAEs). Aspirin-exacerbated respiratory disease is a severe form of chronic rhinosinusitis with nasal polyps in which nearly all patients express anti-SAEs. OBJECTIVES: We aimed to understand antibodies reactive to SAEs and determine whether they recognize SAEs through their complementarity-determining regions (CDRs) or framework regions. METHODS: Labeled staphylococcal enterotoxin (SE) A, SED, and SEE were used to isolate single SAE-specific B cells from the nasal polyps of 3 patients with aspirin-exacerbated respiratory disease by using fluorescence-activated cell sorting. Recombinant antibodies with “matched” heavy and light chains were cloned as IgG(1), and those of high affinity for specific SAEs, assayed by means of ELISA and surface plasmon resonance, were recloned as IgE and antigen-binding fragments. IgE activities were tested in basophil degranulation assays. RESULTS: Thirty-seven SAE-specific, IgG- or IgA-expressing B cells were isolated and yielded 6 anti-SAE clones, 2 each for SEA, SED, and SEE. Competition binding assays revealed that the anti-SEE antibodies recognize nonoverlapping epitopes in SEE. Unexpectedly, each anti-SEE mediated SEE-induced basophil degranulation, and IgG(1) or antigen-binding fragments of each anti-SEE enhanced degranulation by the other anti-SEE. CONCLUSIONS: SEEs can activate basophils by simultaneously binding as antigens in the conventional manner to CDRs and as superantigens to framework regions of anti-SEE IgE in anti-SEE IgE-FcεRI complexes. Anti-SEE IgG(1)s can enhance the activity of anti-SEE IgEs as conventional antibodies through CDRs or simultaneously as conventional antibodies and as “superantibodies” through CDRs and framework regions to SEEs in SEE–anti-SEE IgE-FcεRI complexes. Mosby 2017-04 /pmc/articles/PMC5380656/ /pubmed/27658758 http://dx.doi.org/10.1016/j.jaci.2016.06.066 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Rhinitis, Sinusitis, and Upper Airway Disease
Chen, Jiun-Bo
James, Louisa K.
Davies, Anna M.
Wu, Yu-Chang Bryan
Rimmer, Joanne
Lund, Valerie J.
Chen, Jou-Han
McDonnell, James M.
Chan, Yih-Chih
Hutchins, George H.
Chang, Tse Wen
Sutton, Brian J.
Kariyawasam, Harsha H.
Gould, Hannah J.
Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
title Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
title_full Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
title_fullStr Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
title_full_unstemmed Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
title_short Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
title_sort antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
topic Rhinitis, Sinusitis, and Upper Airway Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380656/
https://www.ncbi.nlm.nih.gov/pubmed/27658758
http://dx.doi.org/10.1016/j.jaci.2016.06.066
work_keys_str_mv AT chenjiunbo antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT jameslouisak antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT daviesannam antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT wuyuchangbryan antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT rimmerjoanne antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT lundvaleriej antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT chenjouhan antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT mcdonnelljamesm antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT chanyihchih antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT hutchinsgeorgeh antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT changtsewen antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT suttonbrianj antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT kariyawasamharshah antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps
AT gouldhannahj antibodiesandsuperantibodiesinpatientswithchronicrhinosinusitiswithnasalpolyps